Procter & Gamble insider files Form 4 with routine equity awards
Rhea-AI Filing Summary
Procter & Gamble (PG) Form 4: Chief Legal Officer & Secretary Susan Street Whaley reported routine equity awards and updated share ownership as of 08/07/2025.
- Direct common-stock holding: 19,670.1407 shares.
- Indirect holding: 6,477.4515 shares via retirement plan trustee.
- New derivative grants: 772 Restricted Stock Units (RSUs) credited as a retirement award on 08/07/2025; no cash outlay.
- Dividend-equivalent RSUs: 6.1043 units (02/18/25) and 6.5759 units (05/15/25) added; both deliverable upon retirement.
- Series A preferred stock adjustment: 0.6322 units credited 07/14/25, convertible to common on distribution.
No shares were sold; all transactions are automatic, price-free allocations tied to dividend equivalents or retirement benefits. The officer now controls roughly 26,148 direct/indirect shares plus 1,833 RSU-equivalent derivatives—immaterial versus PG’s large float, indicating a neutral governance signal rather than a market-moving event.
Positive
- No open-market disposals: insider did not sell any PG shares, avoiding negative perception.
- Additional equity alignment: RSUs and preferred-stock credits modestly increase the officer’s stake.
Negative
- None.
Insights
TL;DR: Routine awards; no buy/sell signal; neutral impact.
The filing shows only non-cash RSU and preferred-stock credits linked to dividends and retirement formulas. No open-market activity occurred, and the total shares involved (<1k new units) are insignificant versus PG’s ~2.4 B shares outstanding. Hence, limited informational value for valuation or sentiment.
TL;DR: Standard benefit accrual, supports alignment, low materiality.
Accrual of RSUs and plan-based preferred shares aligns executive interests with shareholders, but the volumes are too small to influence governance risk assessments. Absence of sales suggests no negative signal, yet investors should view the disclosure as routine compliance.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 772 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| Grant/Award | Series A Preferred Stock | 0.632 | $0.00 | -- |
| Grant/Award | Restricted Stock Units | 6.576 | $0.00 | -- |
| Grant/Award | Restricted Stock Units | 6.104 | $0.00 | -- |
Footnotes (1)
- Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Reflects adjustment to PST through July 14, 2025. Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Higher of $6.82 (adjusted for 2-for-1 stock split effective May 21, 2004) or market price of Common Stock. Shares held by Retirement Plan Trustees. If Officer terminates employment and elects distribution of shares, or, if after age 50 elects alternative investment within Plan, Preferred Stock converted/redeemed at specified conversion/exercise price. Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2025.
